Portfolio concentration
As of February 28, 2026 · N-PORT
Holdings
54
Top-10 weight
67.54%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
15
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1020.2
Holdings
As of February 28, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | DANAHER CORP | — | 2,360,000 | $497.11M | 13.62% |
| 2 | BOSTON SCIENTIFIC CORP | — | 5,850,000 | $449.57M | 12.32% |
| 3 | THERMO FISHER SCIENTIFIC INC | — | 670,000 | $349.14M | 9.57% |
| 4 | INTUITIVE SURGICAL INC | — | 630,000 | $317.21M | 8.69% |
| 5 | EDWARDS LIFESCIENCES CORP | — | 2,360,000 | $204.07M | 5.59% |
| 6 | STRYKER CORP | — | 465,000 | $180.17M | 4.94% |
| 7 | ABBOTT LABS | — | 1,530,000 | $178.02M | 4.88% |
| 8 | MASIMO CORP | — | 560,000 | $98.20M | 2.69% |
| 9 | VEEVA SYSTEMS-A | — | 528,000 | $96.10M | 2.63% |
| 10 | INSULET CORP | — | 360,000 | $88.78M | 2.43% |
| 11 | IQVIA HOLDINGS INC | — | 450,000 | $80.46M | 2.20% |
| 12 | WAYSTAR HOLDING CORP | — | 2,800,000 | $71.82M | 1.97% |
| 13 | REPLIGEN CORP | — | 540,000 | $69.51M | 1.90% |
| 14 | BIO-TECHNE CORP | — | 1,080,000 | $63.72M | 1.75% |
| 15 | WATERS CORP | — | 180,000 | $57.49M | 1.57% |
| 16 | Sartorius Stedim Biotech S.A. | DIM | 260,000 | $56.25M | 1.54% |
| 17 | BECTON DICKINSON and CO | — | 318,000 | $56.12M | 1.54% |
| 18 | CARIS LIFE SCIENCES INC | — | 2,700,000 | $54.38M | 1.49% |
| 19 | MEDLINE INC-A | — | 1,040,000 | $49.41M | 1.35% |
| 20 | IRHYTHM TECHNOLOGIES INC | — | 368,000 | $49.22M | 1.35% |
| 21 | 10X GENOMICS INC | — | 1,967,372 | $45.35M | 1.24% |
| 22 | NATERA INC | — | 200,000 | $41.61M | 1.14% |
| 23 | PENUMBRA INC | — | 120,000 | $41.33M | 1.13% |
| 24 | VERACYTE INC | — | 1,057,562 | $38.70M | 1.06% |
| 25 | GUARDANT HEALTH INC | — | 410,000 | $38.50M | 1.05% |
| 26 | AGILENT TECHNOLOGIES INC | — | 300,000 | $36.41M | 1.00% |
| 27 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 420,000 | $35.39M | 0.97% |
| 28 | Fidelity Securities Lending Cash Central Fund | — | 33,723,974 | $33.73M | 0.92% |
| 29 | LIFESTANCE HEALTH GROUP INC | — | 3,600,000 | $26.06M | 0.71% |
| 30 | KESTRA MEDICAL TECHNOLOGIES INC | — | 1,000,000 | $23.28M | 0.64% |
| 31 | Fidelity Cash Central Fund | — | 22,397,268 | $22.40M | 0.61% |
| 32 | HEARTFLOW INC | — | 920,000 | $21.31M | 0.58% |
| 33 | KARDIUM SRE D-7 PC PP (REDOMICILE CLOSING AUGUST 2025) | — | 19,246,988 | $17.71M | 0.49% |
| 34 | METTLER-TOLEDO INTL INC | — | 12,800 | $17.49M | 0.48% |
| 35 | ELEMENT BIOSCIENCES INC SER D PC PP | — | 2,385,223 | $17.10M | 0.47% |
| 36 | KARDIUM SRE D-7 PC PP (REDOMICILE CLOSING AUGUST 2025) | — | 13,783,189 | $15.85M | 0.43% |
| 37 | BRUKER CORP | — | 360,000 | $14.44M | 0.40% |
| 38 | OMADA HEALTH INC | — | 1,000,000 | $12.28M | 0.34% |
| 39 | SHOULDER INNOVATIONS INC(180 Day Lockup) | — | 874,963 | $11.86M | 0.33% |
| 40 | 10X GENOMICS INC CL B 144A | — | 392,772 | $9.05M | 0.25% |
| 41 | FREENOME HOLDINGS INC SER D PC PP | — | 2,268,156 | $7.39M | 0.20% |
| 42 | ICU MEDICAL INC | — | 40,000 | $6.02M | 0.17% |
| 43 | MANUS BIO INC SER ONE-6 PC PP | — | 1,716,040 | $5.71M | 0.16% |
| 44 | DNA SCRIPT SAS SER C PC PP | — | 28,249 | $4.96M | 0.14% |
| 45 | ALEDADE INC SER F PC PP | — | 175,232 | $4.74M | 0.13% |
| 46 | FREENOME HOLDINGS INC SER D PC PP | — | 1,325,855 | $4.32M | 0.12% |
| 47 | GALVANIZE THERAPEUTICS SER C-1 PC PERP PP | — | 3,641,139 | $2.62M | 0.07% |
| 48 | ASIMOV INC SER B PC PP | — | 97,985 | $2.53M | 0.07% |
| 49 | DOXIMITY INC-A | — | 100,000 | $2.45M | 0.07% |
| 50 | SALUDA MEDICAL INC WT PP | — | 293,080 | $2.17M | 0.06% |
1 / 2
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.